Search

Background The efficacy of the powered rasp, a new reciprocating motion device for arthroscopic resection of osteophytes, has not been verified. The aim of this study was to compare the intraoperative efficacy of the powered rasp in arthroscopic resection of anterior ankle osteophytes to that of the conventional burr. Methods A total of 49 consecutive patients who underwent arthroscopic resection of anterior ankle osteophytes (26 patients with the conventional burr and 23 patients with the powered rasp) were retrospectively reviewed. The preoperative volume of each osteophyte was measured using computerized tomography scan and three-dimensional software. The resection time was measured by review of the individual arthroscopy video, and the estimated resection rate was calculated as the volume of osteophytes/resection time. Results The preoperative volume of osteophytes was not different between the two groups (847.8 ± 685.3 mm3 in the conventional burr and 913.3 ± 605.8 mm3 in the powered rasp, p = 0.726). The resection time was 442.4 ± 216.6 s (seconds) in the conventional burr and 386.4 ± 186.3 s in the powered rasp, and the estimated resection rate was 1.8 ± 1.0 mm3/s with the conventional burr and 2.4 ± 1.3 mm3/s with the powered rasp. These measurements were not significantly different between the two groups (p = 0.340 and 0.083, respectively). Conclusion The intraoperative efficacy of the powered rasp did not show superiority to that of the conventional burr in arthroscopic resection of anterior ankle osteophytes. Level of evidence Level III, retrospective comparative study.

A 2 × 2 factorial arrangement was used to investigate the interactions between lactose levels (100 g/kg versus 200 g/kg) and Lactobacillus -based fermentation product (FP; 0 and 1 × 10 11 CFU Lactobacillus casei /kg) on weanling piglet performance and nutrient digestibility. Two hundred and forty weaned piglets (24 days old, 7.05 kg live weight) were blocked on the basis of live weight and assigned to one of four dietary treatments with six replicates and 10 piglets per replicate in two phases (phase 1, from d 1 to 14; phase 2, from d 14 to 28). Volatile fatty acid concentrations and bacterial counts were performed in ileal, cecal, and colonic contents. In phase Ⅰ, ADG was increased (P Salmonella spp. in the ileum. The pH of colon digesta was lower (P Lactobacillus spp. was increased (P E. coli . This study demonstrates that dietary FP improved the growth performance and DM digestibility of weanling pigs. When the dietary FP, and the lactose level were combined there was no evidence of an interaction on growth performance. However, both lactose and FP decreased the emissions of total organic carbon and ammonium.

Summary Overexpression of mitotic arrest deficient 2 (MAD2) and/or cell division cycle 20 (CDC20) in the spindle assembly checkpoint leads to chromosomal instability and aneuploidy. Cell-in-cell (CIC) structures are formed by the process where cancer or immune cells are internalized into adjacent host cancer cells. Here, we investigated the clinicopathological significances of spindle assembly checkpoint protein overexpression and CIC structures in 829 cases of normal, premalignant, and gastric cancer (GC) lesions. MAD2 and CDC20 expressions were significantly increased in intestinal metaplasia, low-grade dysplasia, high-grade dysplasia (HGD), and early GC than normal mucosa, and their expression levels were the highest in HGD. Interestingly, CDC20 immunohistochemistry specifically stained the outer cells of CIC structures, which were the most frequently observed in early GC. In univariate analyses, MAD2 and CDC20 overexpressions and CIC formation were associated with older age, intestinal histology, lower tumor-node-metastasis stage, and longer recurrence-free survival and cancer-specific survival of GC patients. In multivariate survival analyses, MAD2 and CDC20 overexpressions were associated with better recurrence-free survival (hazard ratio, 0.61; P = .012) and cancer-specific survival (hazard ratio, 0.63; P = .043), respectively. In conclusion, MAD2 and CDC20 are the most expressed in HGD, suggesting their roles in the early stage of gastric carcinogenesis, whereas their overexpressions in GC are associated with intestinal histology and favorable clinicopathological parameters, which may be useful for immunohistochemical classification of chromosomal instability–type GC. Moreover, CDC20 is a novel immunohistochemical marker for highlighting CIC structures.

Silicone-based fillers have been applied in several branches of medicine, such as soft tissue augmentation, because of their stability and durability. However, the inherently hydrophobic surfaces of silicone occasionally cause excessive deposition of the fibrous matrix in vivo, leading to severe fibrosis. In this study, we evaluated the use of a zwitterionic copolymer to offer a facile surface treatment method for silicone-based fillers and performed a preclinical trial of the formulation as-prepared. The copolymer has amphiphilic moieties, which act as macromolecular surfactants that can functionalize and stabilize the silicone particles during fabrication. The effectiveness and safety of the particle filler were evaluated histologically by scoring the peri-implant tissues into previously defined categories. Our results suggest that zwitterion-coated silicone fillers can inhibit protein adsorption, and thus, help attenuate foreign body reactions in a rat model. This demonstrates their potential for wide application in different fields within the discipline of medicine.

This work was carried out to elucidate the mechanism underlying the formation of zirconium and titanium oxide mixed layers on titanium substrates via plasma electrolytic oxidation (PEO) and plasma-enhanced electrophoresis. A series of constant high anodic currents were applied to KOH-based electrolytes containing ZrO2 nanoparticles with four different concentrations of K4P2O7. Scanning electron microscopy observations indicated that the coating layer formed in the electrolyte without K4P2O7 was underdeveloped owing to the absence of phosphate ions, which act as a complexing agent for uniform coating growth. Compositional analyses using X-ray diffraction and X-ray photoelectron spectroscopy revealed that the coating layer formed in the electrolyte with 0.015 M K4P2O7 consisted predominately of ZrO2, whereas increasing amounts of additional Zr compounds, such as ZrTiO4, and Zr–P compounds were found in the coating layers formed in the electrolytes with 0.03 and 0.045 M K4P2O7. The formation of such compounds could be mainly attributed to electrochemical reactions between ZrO2 and other components in the electrolytes owing to the high electrical energy of microarcs. Consequently, excessive phosphate ions in the electrolytes with 0.03 and 0.045 M K4P2O7 act as reactants for the formation of Zr–P compounds rather than complexing agents for the growth of the oxide layer.

Mesoporous TiO2 particles have been extensively used as scattering particles in dye-sensitized solar cells (DSSCs), because of their high scattering properties and additional carrier derived from their high surface area. However, the latter effect was not fully utilized, since generated additional carriers cannot be efficiently collected. Hence, for the efficient DSSCs, utilizing their high surface area was remained as a key issue. Herein, we synthesized three-dimensionally ordered mesoporous (3DOm) TiO2 particles and put them into the photoanode as scatterers for DSSCs. These scattering particles were embedded in the photoanode, to utilize their specific morphology. The synthesized 3DOm TiO2 particles increased total surface area and dye uptake of the photoanode without losing cells’ scattering properties. These effects were clearly reflected on the photovoltaic parameters in DSSCs, as a gradual increase of current density with respect to the 3DOm TiO2 particles ratio. As a consequence, we demonstrated scattering particle design and appropriate cell configuration for efficient DSSCs, with 11% enhancement in the conversion efficiency.

The derangement of the cell cycle facilitates uncontrolled cell proliferation and acquisition of genetic alterations favorable for malignancy. However, the protein expression profiles of E2 F family cell cycle regulators in clear cell renal cell carcinoma (ccRCC) have not yet been thoroughly investigated. In this study, we aimed to examine the protein expression profiles and prognostic value of E2 F1, E2 F3, and E2 F4 in ccRCC cases. The immunohistochemical expression of E2 F1, E2 F3, and E2 F4 was quantitatively scored in 180 ccRCC tumor tissues and 79 normal kidney tissues. The prognostic implications of these E2 F members were determined. We found that ccRCC tumor cells showed higher nuclear expression of E2 F1, E2 F3 and E2 F4 than normal kidney samples. High E2 F1 and E2 F3 expression in tumor cells was associated with poor prognostic factors of ccRCC, whereas high E2 F4 correlated with beneficial prognostic factors. High expression of E2 F1 and E2 F3 in tumor cells was correlated with a poor overall and recurrence-free survival, while high E2 F4 expression did not. In conclusion, E2 F1, E2 F3 and E2 F4 may function as oncogenes during tumorigenesis of ccRCC, although they contribute to the progression of ccRCC in different ways. Additional studies are required to clarify the conflicting role of E2 F4 in the tumor evolution of ccRCC.

Clear cell renal cell carcinomas (ccRCCs) have inactivation of the von Hippel-Lindau protein, leading to the accumulation of hypoxia-inducible factor-α (HIF-α). HIF-1α induces aerobic glycolysis, the Warburg effect, whereas HIF-2α functions as an oncoprotein. Lactate transport through monocarboxylate transporters (MCTs) and the chaperone CD147 is essential for high glycolytic cancer cell survival. To elucidate the clinical significance of MCT1, MCT4, and CD147 expression, we investigated their expressions by immunohistochemistry in ccRCC specimens and validated the results by an open-access The Cancer Genome Atlas data analysis. Overexpression of MCT1, MCT4, and CD147 was observed in 49.4% (89/180), 39.4% (71/180), and 79.4% (143/180) of ccRCC patients, respectively. High MCT1 expression was associated with older age (P = .017), larger tumor size (P = .015), and advanced TNM stage (P = .012). However, MCT4 overexpression was not related to any variables. CD147 overexpression correlated with high grade (P = .005), tumor necrosis (P = .016), and larger tumor size (P = .038). In univariate analysis, high expression of MCT1 (P < .001), MCT4 (P = .016), and CD147 (P = .02) was linked to short progression-free survival. In multivariate analysis, high MCT1 expression was associated with worse progression-free survival (P = .001). In conclusion, high expression of MCT1 and CD147 is associated with poor prognostic factors. Overexpression of MCT1, MCT4, and CD147 predicts tumor progression. Reversing the Warburg effect by targeting the lactate transporters may be a useful strategy to prevent ccRCC progression.

This paper presents a beamforming technique for locating impulsive sound source. The conventional frequency-domain beamformer is advantageous for localizing noise sources for a certain frequency band of concern, but the existence of many frequency components in the wide-band spectrum of impulsive noise makes the beamforming image less clear. In contrast to a frequency-domain beamformer, it has been reported that a time-domain beamformer can be better suited for transient signals. Although both frequency- and time-domain beamformers produce the same result for the beamforming power, which is defined as the RMS value of its output, we can use alternative directional estimators such as the peak value to enhance the performance of a time-domain beamformer. In this study, the performance of two different directional estimators, the peak and RMS output values, are investigated and compared with the incoherent measurement noise embedded in multiple microphone signals. The impulsive noise source is modeled as a triangular pulse, and the beamwidth and side lobe level of the time-domain beamformer are formulated as functions of the pulse duration, the microphone spacing, and the number of microphones. The proposed formula is verified via experiments in an anechoic chamber using a uniformly spaced linear array, and the results show that the peak estimation of beamformer output determines the location with better spatial resolution and a lower side lobe level than RMS estimation.

This study employs for the first time surface-nitrided Ni foam as a counter-electrode free of Pt and transparent conducting oxides (TCOs) to realize a cost-effective counter electrode for dye-sensitized solar cells (DSSCs). This electrode simultaneously features high catalytic activity for triiodide reduction and high conductivity in a single layer. The nitrided Ni foam is synthesized by nitridation treatment of open-cell Ni foam in an ammonia atmosphere. This electrode presents high catalytic activity on the nitrided surface and easy electron transport ability in the three-dimensional, interconnected metallic structure. This study provides a preliminary design concept for utilizing the nitrided Ni foam as a promising cost-effective counter electrode that does not require expensive Pt and TCO.

An inverse-opal poly(3,4-ethylene dioxythiophene) (PEDOT) electrode was fabricated by electrodeposition of EDOT onto a PEDOT:poly(styrene sulfonate) filler in a self-assembled polystyrene template. By this novel fabrication method, the inverse-opal electrode was directly assembled into a dye-sensitized solar cell (DSSC) as a Pt-free counter electrode without any additional processing. This inverse-opal PEDOT electrode exhibits superior electrocatalytic activity and easy electrolyte diffusion in the electrode, as the inverse-opal electrode provides a porous morphology. The improved reflectivity of the inverse-opal electrode was also observed in the incident-photon conversion-efficiency spectra at low wavelength, which was a characteristic of its well-ordered structure. Therefore, the inverse-opal PEDOT electrode could successfully act as an alternative counter electrode for DSSCs to replace Pt in the counter electrode.

Many loudspeakers in newer flat television systems are mounted on the bottom of the television, with their diaphragms facing downward, so as to be hidden inside the TV frame. This kind of loudspeaker installation, called downfiring , induces relatively large reflections from the walls of a room. The increased reflections inevitably change the impulse response of the loudspeakers, which leads to a perceptible distortion in sound quality. In this study, an equalization procedure to resolve the distortion due to downfiring loudspeakers is presented. The change in the early-arriving sound from the room reflections was analyzed, and the specific experimental environment was set up to measure the early reflections for designing a single-channel equalization filter. The inverse technique for the single-input multiple-output (SIMO) system was applied such that both the magnitude and phase responses from downfiring loudspeakers can be equalized at multiple listener positions. We also investigated the possible equalization range in space and time, for which the single-channel filter can work effectively. The performance of the filter designed for the equalization range was then demonstrated by experiments. The experiments were performed using a flat television mock-up installed in a reflective environment. For the performance evaluation of the proposed method, we employed two different measures that can represent the magnitude and phase distortions: the mean squared error of the magnitude and an energy decay curve. The experimental results demonstrate that the single-channel filter can reduce the early reflections from a downfiring loudspeaker by a considerable amount.

Summary Activated B-cell–like subtype of diffuse large B-cell lymphoma (DLBCL) is characterized by chronic active B-cell receptor signaling and a constitutive activation of the nuclear factor κ B pathway. As a driving force of nuclear factor κ B overactivity, myeloid differentiation primary response gene 88 ( MYD88 ) L265P mutation occurs in activated B-cell–like DLBCL. However, the MYD88 L265P mutation has not yet been studied in conjunction with MYD88 protein expression in DLBCL cases. Thus, we investigated MYD88 expression in 124 DLBCL specimens by immunohistochemistry. In addition, the MYD88 L265P mutation was examined by polymerase chain reaction and direct DNA sequencing. MYD88 was overexpressed in 38.7% (48/124) of DLBCL cases. MYD88 was expressed in the cytoplasm of lymphoma cells. MYD88 overexpression was associated with older age ( P = .016) and tumor recurrence ( P = .007). In univariate analysis, MYD88 overexpression was correlated with shortened disease-free survival (DFS) of DLBCL ( P = .013) and non–germinal center B-cell–like DLBCL ( P = .034). In multivariate analysis, MYD88 overexpression was an independent factor for reduced DFS ( P = .025). MYD88 L265P mutation was found in 6.5% (8/124) of DLBCL cases. All but 1 case were of non–germinal center B-cell–like subtype. The MYD88 L265P mutation was not associated with MYD88 expression (Spearman ρ = −0.074) and clinicopathologic parameters of DLBCL. The data indicate that high MYD88 expression is significantly associated with tumor recurrence and shortened DFS in patients with DLBCL. In addition, the incidence of MYD88 L265P mutation in Korea is much lower than previously reported. Thus, MYD88 may be crucial for lymphoma progression, independent of MYD88 L265P mutation.

Background and Aims Plasminogen activator inhibitor type 1 (PAI-1) is associated with poor prognosis in breast cancer. Transcriptional expression of the PAI-1 can be controlled by PAI-1 promoter 4G/5G polymorphism. However, the significance of PAI-1 promoter 4G/5G polymorphism in breast cancer patients is contentious. To address this controversy, we conducted a meta-analysis for the relationships between PAI-1 promoter polymorphism and clinicopathological characteristics of breast cancer. Methods Relevant published studies were identified using a search of PubMed, Embase, and the ISI Web of Science. The effect sizes of PAI-1 promoter 4G/5G polymorphism on breast cancer risk, lymph node metastasis, histologic grade, and overall survival were calculated by odds ratio (OR) or hazard ratio. The effect sizes were combined using a random-effects model. Results Individuals with 4G/4G genotype had a higher risk of breast cancer than those with the combined 4G/5G and 5G/5G genotypes (OR = 1.388; p = 0.031). Breast cancer patients with the 5G/5G genotype displayed lymph node metastasis more than patients with either the combined other genotypes (OR = 1.495; p = 0.027) or with the 4G/4G genotype (OR = 1.623; p = 0.018). However, the PAI-1 promoter 4G/5G polymorphism was not associated with histological grade or overall survival. Conclusions PAI-1 promoter 4G/5G polymorphism is associated with a relatively increased risk of breast cancer development and lymph node metastasis.

Background and Aims Tissue inhibitor of metalloproteinase-1 (TIMP-1) is a small secretory glycoprotein with multifunctional activity including anti-apoptosis and the inhibition of matrix metalloproteinase in invasive breast carcinomas. There have been contradictory results as to whether TIMP-1 is a poor or good prognostic factor in breast cancer patients. To address this controversy, we conducted a meta-analysis for the relationship between TIMP-1 levels and prognostic parameters in the breast cancer. Methods The relevant published studies were pooled according to the defined selection criteria. The effect sizes of overall survival and prognostic parameters were calculated by a hazard ratio (HR) or an odds ratio (OR). HRs or ORs were combined using a random-effects model. Results Survival outcomes between high or elevated and low or normal serum TIMP-1 levels were compared by uni- and multivariate analyses involving 886 and 844 breast cancer patients, respectively. Patients with high or elevated serum TIMP-1 levels had unfavorable survival outcomes compared to patients with low or normal serum TIMP-1 levels in the uni- and multivariate analyses (HR, 1.7 and 2.4; p p = 0.033, respectively). However, no survival difference was evident in the data from tissue TIMP-1 levels by enzyme-linked immunosorbent assay and the expression of tissue TIMP-1 mRNA. The high or positive immunohistochemical expression of tissue TIMP-1 protein was not related to adjusted and unadjusted HRs, lymph node metastasis, and clinical stages. Conclusions This meta-analysis indicates that serum TIMP-1 levels may be useful for predicting survival outcomes of invasive breast cancer patients.

ZnO-coated LiCoO 2 particles are prepared by plasma-enhanced chemical vapour deposition (PE-CVD) in a coating range from 0.08 to 0.49 wt.%, and examined using field emission-scanning electron microscopy (FE-SEM), X-ray diffraction (XRD), and atomic absorption spectroscopy (AAS), with particular focus on surface characteristics. From charge-discharge cycling tests in the range of 3.0–4.5 V, the ZnO coating has little effect on the discharge capacity in the first few cycles, but the coating effectively improves the capacity retention after prolonged cycling. In the experimental range studied, the optimum amount of ZnO coating which maximizes the capacity retention is found to be 0.21 wt.%. An excessive amount of ZnO coating causes a decrease in both cyclic performance and thermal stability. The possible reasons for enhanced cycleability and thermal stability afforded by the ZnO coating are discussed from the viewpoint of the surface morphology of the bare and coated LiCoO 2 particles and their impedance spectra.

The tissue inhibitor of metalloproteinase-1 (TIMP-1) is a stromal factor that promotes plasmablastic differentiation, and the survival of germinal center B-cells. The expression of TIMP-1 is known to be correlated with a subset of non-Hodgkin lymphoma at the mRNA level, and Epstein-Barr virus infection in vitro. To characterize TIMP-1(+) diffuse large B-cell lymphoma, TIMP-1 expression was investigated in tissue microarrays from 182 cases of de novo diffuse large B-cell lymphoma and compared with prognostic factors, immunophenotypes, and Epstein-Barr virus infection status. TIMP-1 was expressed not only in tumor cells themselves, in 14 of 182 cases (8%), designated as TIMP-1(+) diffuse large B-cell lymphoma, but also in stromal cells like fibroblasts and endothelial cells. In univariate analysis and hierarchical clustering, our findings suggest that TIMP-1 expression may represent a distinct subgroup. In multivariate analysis, TIMP-1(+) diffuse large B-cell lymphoma (n=14) was associated with unfavorable outcomes compared to TIMP-1(-) diffuse large B-cell lymphoma (n=168) (odds ratio=2.5, P=0.049). Together with TIMP-1 expression, age (greater than 60 years), the presence of B-symptoms, abnormal lactate dehydrogenase level, or more advanced stage (III/IV) was correlated with a poor overall survival. However, TIMP-1 expression in diffuse large B-cell lymphoma was not correlated with other prognostic factors including: clinical stage, international prognostic index score, and nongerminal center B-cell phenotype, as well as Epstein-Barr virus infection. Our results suggest that TIMP-1 expression may be an independent negative prognostic factor in patients with diffuse large B-cell lymphoma.

As an effective and safe strategy to overcome the limits of therapeutic nucleic acid or adenovirus (Ad) vectors for in vivo application, various technologies to modify the surface of vectors with nonimmunogenic/biocompatible polymers have been emerging in the field of gene therapy. However, the transfection efficacy of the polymer to transfer genetic matrials is still relatively weak. To develop more advanced and effective polymer to deliver not only Ad vectors, but also nucleic acids, 6 biocompatible polymers were newly designed and synthesized to different sizes (2k, 3,4k, or 5k) of poly(ethylene) glycol (PEG) and different numbers of amine groups (2 or 5) based on methoxy poly(ethylene glycol)-b-poly{N-[N-(2-aminoethyl)-2-aminoethyl]-L-glutamate (PNLG). We characterized size distribution and surface charge of 6 PNLGs after complexation with either nucleic acid or Ad. Among all 6 PNLGs, the 5amine group PNLG showed the strongest efficacy in delivering nucleic acid as well as Ad vectors. Interestingly, cellular uptake results showed higher uptake ability in Ad complexed with 2 amine group PNLGs is more essential than the surface charge for cellular uptake in polymers with charges greater than 30 mV. Moreover, the endosome escape ability of Ad/PNLGs increased depending on the number of amine groups, but decreased by PEG size. Cancer cell killing efficacy and immune response studies of oncolytic Ad/PNLGs showed 5 amine group PNLG to be a more effective and safe carrier for delivering Ad. Overall, these studies provide new insights into the functional mechanism of polymer-based approaches to either nucleic acid or Ad/nanocomplex. Furthermore, the identified ideal biocompatible PNLG polymer formulation (5 amine/2k PEG for nucleic acid, 5 amine/5k PEG for Ad) demonstrated high transduction efficiency as well as therapeutic value (efficacy and safety) and thus has strong potential for in vivo therapeutic use in the future.

The in vivo reconstruction of conjunctiva was investigated by using modified poly(lactide-co-glycolide) (PLGA) 50/50 scaffolds. The porous PLGA matrices were prepared by a solvent-casting particulate-leaching method with NaCl, then modified with collagen, hyaluronic acid (HA) or/and human amniotic membrane (AM) component. The growth of corneal epithelial cells and human stromal fibroblasts on the scaffolds was investigated in vitro. All the modified PLGA scaffolds demonstrated enhanced cell adhesion and proliferation as compared to PLGA untreated, and the number of cells proliferated after 1 week was increased in the order of PLGA

Oncolytic adenoviruses (Ads) have shown great promise in cancer gene therapy but their efficacy has been compromised by potent immunological, biochemical, and specific tumor-targeting limitations. To take full advantage of the innate cancer-specific killing potency of oncolytic Ads but also exploit the subtleties of the tumor microenvironment, we have generated a pH-sensitive and bio-reducible polymer (PPCBA)-coated oncolytic Ad. Ad-PPCBA complexes showed higher cellular uptake at pH 6.0 than pH 7.4 in both high and low coxsackie and adenovirus receptor-(CAR)-expressing cells, thereby demonstrating Ad-PPCBA's ability to target the low pH hypoxic tumor microenvironment and overcome CAR dependence for target cell uptake. Endocytic mechanism studies indicated that Ad-PPCBA internalization is mediated by macropinocytosis instead of the CAR-dependent endocytic pathway that internalizes naked Ad. VEGF-specific shRNA-expressing oncolytic Ad complexed with PPCBA (RdB/shVEGF-PPCBA) elicited much more potent suppression of U87 human brain cancer cell VEGF gene expression in vitro, and human breast cancer MCF7 cell/Matrigel plug vascularization in a mouse model, when cancer cells had been previously infected at pH 6.0 versus pH 7.4. Moreover, intratumorally and intravenously injected RdB/shVEGF-PPCBA nanocomplexes elicited significantly higher therapeutic efficacy than naked virus in U87-tumor mouse xenograft models, reducing IL-6, ALT, and AST serum levels. These data demonstrated PPCBA's biocompatibility and capability to shield the Ad surface to prevent innate immune response against Ad after both intratumoral and systemic administration. Taken together, these results demonstrate that smart, tumor-specific, oncolytic Ad-PPCBA complexes can be exploited to treat both primary and metastatic tumors.